Placebo-controlled Trial in Subjects at Ultra-high Risk for Psychosis With Omega-3 Fatty Acids in Europe
type: MedicalStudy
description: Placebo-controlled Trial in Subjects at Ultra-high Risk for Psychosis With Omega-3 Fatty Acids in Europe
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE4
start date: 2016-09-30
end date: 2023-02-01
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT02597439
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Rene Kahn
study subject: Ultra High Risk for Psychosis
keywords: PHASE4
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Ultra High Risk for Psychosis

AI Analytics
type: Organization